Associated Papers
Common Variants in Osteopontin and CD44 Genes as Predictors of Treatment Outcome in Radiotherapy and Chemoradiotherapy for Non-Small Cell Lung Cancer.
Gałecki S et al.
Cells, 2023
OPN gene polymorphisms, rs17524488 GG/G, rs11730582 T/C, and rs9138 C/A, and cancer risk in a Chinese population.
Mi Y et al.
Scientific Reports, 2015
Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma.
Dong QZ et al.
Hepatology (baltimore, Md.), 2013
The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.
Chiu YW et al.
Oral Oncology, 2010
A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression.
Hummelshoj T et al.
Molecular Immunology, 2006
Select a paper to view details